Scarica l'app Stockscreener
6.99
1.60%
0.11
Dopo l'orario di chiusura:
6.98
-0.010
-0.14%
Precedente Chiudi:
$6.88
Aprire:
$6.81
Volume 24 ore:
63,856
Relative Volume:
0.40
Capitalizzazione di mercato:
$67.08M
Reddito:
$24.99M
Utile/perdita netta:
$-116.80M
Rapporto P/E:
-0.5195
EPS:
-13.4543
Flusso di cassa netto:
$-96.98M
1 W Prestazione:
+3.86%
1M Prestazione:
-4.12%
6M Prestazione:
-47.23%
1 anno Prestazione:
-39.66%
Intervallo 1D:
$6.735
$7.01
Intervallo di 1 settimana:
$6.01
$7.0572
Portata 52W:
$6.01
$17.44
Adicet Bio Inc Stock (ACET) Company Profile
Nome
Adicet Bio Inc
Settore
Industria
Telefono
617-482-2333
Indirizzo
131 DARTMOUTH STREET, BOSTON
Compare ACET vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACET
Adicet Bio Inc
|
6.99 | 67.08M | 24.99M | -116.80M | -96.98M | -13.45 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Adicet Bio Inc Stock (ACET) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-09-30 | Ripresa | Guggenheim | Buy |
| 2024-09-11 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-06-27 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-06-27 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2023-06-01 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-09-21 | Iniziato | JP Morgan | Overweight |
| 2022-03-31 | Iniziato | SMBC Nikko | Outperform |
| 2022-03-08 | Iniziato | Truist | Buy |
| 2022-03-04 | Iniziato | Jefferies | Buy |
| 2021-05-18 | Iniziato | BTIG Research | Buy |
| 2021-04-23 | Iniziato | H.C. Wainwright | Buy |
| 2021-04-14 | Iniziato | Canaccord Genuity | Buy |
| 2021-04-08 | Iniziato | Guggenheim | Buy |
| 2020-11-04 | Iniziato | B. Riley Securities | Buy |
| 2020-10-27 | Iniziato | JMP Securities | Mkt Outperform |
| 2020-10-16 | Iniziato | Wedbush | Outperform |
Mostra tutto
Adicet Bio Inc Borsa (ACET) Ultime notizie
ACET PE Ratio & Valuation, Is ACET Overvalued - Intellectia AI
Analyst Calls: What analysts say about Adicet Bio Inc stockMarket Sentiment Review & AI Driven Stock Price Forecasts - baoquankhu1.vn
Inflation Data: Can Adicet Bio Inc continue delivering strong returnsEarnings Recap Summary & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
ACET Stock Price, Quote & Chart | ADICET BIO INC (NASDAQ:ACET) - ChartMill
Adicet Bio Inc. R (1IJ.F) options chain - Yahoo Finance UK
ACET Technical Analysis & Stock Price Forecast - Intellectia AI
Buybacks Report: Is Adicet Bio Inc on track to beat earningsEarnings Risk Summary & Fast Moving Stock Trade Plans - baoquankhu1.vn
Aug Setups: What is the earnings history of Adicet Bio IncWeekly Trade Summary & Reliable Momentum Entry Alerts - baoquankhu1.vn
Adicet Bio (ACET) price target decreased by 13.82% to 54.06 - MSN
Adicet Bio (ACET) upgraded to buy: Here's why - MSN
CFO at Adicet Bio (ACET) receives stock options on 43,361 shares - Stock Titan
Adicet Bio (ACET) CEO granted 468,555 stock options at $6.81 strike - Stock Titan
Adicet Bio (ACET) CMO receives 72,555 stock options at $6.81 exercise price - Stock Titan
Stock options granted to Adicet Bio (ACET) chief technology officer - stocktitan.net
Adicet Bio (NASDAQ: ACET) grants 72,555 stock options to Chief Scientific Officer - Stock Titan
Adicet Bio, Inc. (NASDAQ:ACET) Given Average Rating of "Moderate Buy" by Analysts - marketbeat.com
If You Invested $1,000 in Adicet Bio Inc (ACET) - Stock Titan
Rally Mode: Should I set a stop loss on Adicet Bio Inc2026 Technical Patterns & Low Risk High Reward Ideas - baoquankhu1.vn
Insider Trends: Can Adicet Bio Inc ride the EV waveTrade Signal Summary & Fast Gain Stock Tips - baoquankhu1.vn
Stock Recap: Is Adicet Bio Inc stock a good dividend stock2026 Action & Weekly Market Pulse Alerts - baoquankhu1.vn
Adicet Bio (NASDAQ:ACET) Upgraded at Truist Financial - MarketBeat
What is HC Wainwright's Estimate for Adicet Bio Q1 Earnings? - MarketBeat
Adicet Bio (ACET) Raised to Buy: Discover the Reasons - Bitget
Adicet Bio (ACET) Upgraded to Buy: Here's Why - Yahoo Finance
[EFFECT] Adicet Bio, Inc. SEC Filing - Stock Titan
H.C. Wainwright cuts Adicet Bio stock price target on higher discount rate By Investing.com - Investing.com South Africa
H.C. Wainwright cuts Adicet Bio stock price target on higher discount rate - Investing.com
Adicet Bio (NASDAQ:ACET) Price Target Cut to $27.00 by Analysts at HC Wainwright - MarketBeat
Is Adicet Bio Inc currently under institutional pressure2026 Bull vs Bear & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Adicet Bio Inc. R (1IJ.DU) - Yahoo! Finance Canada
Analysts Offer Insights on Healthcare Companies: Adicet Bio (ACET), Teleflex (TFX) and Medacta Group SA (OtherMEDGF) - The Globe and Mail
IPO Launch: Is Adicet Bio Inc on track to beat earningsWeekly Trend Report & Community Consensus Trade Signals - baoquankhu1.vn
Guggenheim Keeps Their Buy Rating on Adicet Bio (ACET) - The Globe and Mail
Adicet Bio, Inc. (ACET) Competitors - Meyka
Aug Patterns: Can Adicet Bio Inc continue delivering strong returns2026 Highlights & Target Return Focused Picks - baoquankhu1.vn
Guggenheim cuts Adicet Bio stock price target to $100 on valuation - Investing.com Australia
Clinical Trial Uncertainty Puts Adicet Bio’s Prula-cel Program and Financial Outlook at Risk - TipRanks
Guggenheim Issues Pessimistic Forecast for Adicet Bio (NASDAQ:ACET) Stock Price - MarketBeat
Guggenheim cuts Adicet Bio stock price target to $100 on valuation By Investing.com - Investing.com South Africa
Adicet Bio Reports Strong 2025 Financial Results and Advances Key Autoimmune and Cancer Cell Therapy Programs - Minichart
Adicet Bio, Inc. 2025 Annual Report: Allogeneic Gamma Delta T Cell Therapy for Autoimmune Diseases and Cancer – Strategy, Risks, and Financial Overview - Minichart
Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company - PharmiWeb.com
Adicet Bio (NASDAQ: ACET) files $250M shelf to issue stock, debt, warrants - Stock Titan
Adicet Bio (NASDAQ:ACET) Releases Earnings Results, Beats Expectations By $0.29 EPS - MarketBeat
Adicet Bio 10-K: $0 Revenue, $(16.95) EPS on $(116.8M) Net Loss - TradingView
ACET: 2025 net loss was $116.8M; prula-cel advanced in autoimmune trials, cash runway into 2027 - TradingView
ACET: Clinical pipeline advances and solid cash position support continued execution into 2027 - TradingView
Adicet Bio (NASDAQ: ACET) outlines 2025 loss and cash runway into 2027 - Stock Titan
Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress - Bluefield Daily Telegraph
ACET SEC FilingsAdicet Bio Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Adicet Bio (NASDAQ:ACET) Stock Passes Below 200 Day Moving AverageHere's What Happened - MarketBeat
Adicet Bio Inc Azioni (ACET) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):